Pharsight

Sezaby patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11857683 SUN PHARM INDS INC Stabilization of phenobarbital sodium for injection
Apr, 2042

(17 years from now)

Sezaby is owned by Sun Pharm Inds Inc.

Sezaby contains Phenobarbital Sodium.

Sezaby has a total of 1 drug patent out of which 0 drug patents have expired.

Sezaby was authorised for market use on 17 November, 2022.

Sezaby is available in powder;intravenous dosage forms.

Sezaby can be used as method of treating neonatal seizures.

The generics of Sezaby are possible to be released after 07 April, 2042.

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-414) Nov 17, 2029

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using PHENOBARBITAL SODIUM ingredient

Market Authorisation Date: 17 November, 2022

Treatment: Method of treating neonatal seizures

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

SEZABY family patents

Family Patents